Field Trip's new strategic partnership will facilitate bringing its ketamine-assisted psychotherapy for PTSD to military veterans.
Exploring the companies and themes that make up this emerging and exciting new sector
Mind Cure Announces Addition of Neuroscientist Dr. Wolfram Tetzlaff to Scientific Advisory Board
Mind Cure adds an expert in neuroscience and nutrition to its Advisory Board.
Pharmather (CSE:PHRM) Is The Latest Psychedelics IPO
The newest psychedelics company plans to focus on both ketamine- and psilocybin-assisted psychedelics R&D.
Field Trip Adds Acclaimed Physician, Dr. Andrew Weil, to Medical Advisory Board
Field Trip has appointed a leader in holistic and integrative medicine to its Medical Advisory Board.
Mind Cure Assembles Cast For Psychedelic Drug Success
After a series of significant corporate appointments, Mind Cure is poised to advance its operations.
Numinus Commences Psilocybe Mushroom Cultivation
Numinus commences psilocybin cultivation as part of its "ecosystem approach" to psychedelic drug therapy.
Release: Health and Wellness Industry Tastemaker Jon Bier Joins Mind Cure's (CSE: MCUR) Advisory Board
Mr. Bier is a communications and strategy expert who has played a key role in building brands such as Four Sigmatic and WHOOP
Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin
Mydecine's new patent application may lead to a way to derive the medicinal benefits of psilocybin at lower doses.
Mind Cure Welcomes Dr. Jason Wallach to Scientific Advisory Board
Mind Cure's latest addition to its Scientific Advisory Board is a noted expert in psychedelic medicine, published researcher, and professor of pharmacology.
Prominent Psychedelic Medicine Researcher Added To Mind Cure Team
This is Mind Cure's third high-profile addition to its Scientific Advisory Board in the last week.
Upstart Mind Cure (CSE:MCUR) Targets Disrupting $300 Billion Industry
The mental healthcare industry is ripe for innovation. And companies like Mind Cure (CSE: MCUR), which recently completed its IPO, are set to lead the way.
Mind Cure Welcomes Award-Winning Journalist and Science Researcher Hamilton Morris to Advisory Board
Noted psychedelic drug expert, Hamilton Morris, is the latest addition to Mind Cure's advisory board.